Michelle Easton
🏛️ Revolving DoorFormer Government Positions:
Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin
Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham
🤖
AI Overview
Michelle Easton has appeared in 2,506 federal lobbying filings at Tarplin, Downs & Young, LLC, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 10 policy areas.
2,506
Total Filings
1
Firms
50
Clients
10
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 345 | 30 |
| 2019 | 354 | 34 |
| 2020 | 500 | 45 |
| 2021 | 591 | 51 |
| 2022 | 706 | 54 |
| 2023 | 9 | 2 |
| 2024 | 1 | 1 |
Firms
Tarplin, Downs & Young, LLC2506 filings
Top Clients
Biotechnology Industry Organization100 filings
Abbott (Formerly Known as Alere INC.)94 filings
Vertex Pharmaceuticals Incorporated94 filings
Merck80 filings
Blue Cross Blue Shield Association80 filings
Abbvie INC.76 filings
Astrazeneca72 filings
Bd (Becton, Dickinson and Company)72 filings
Alzheimer's Association64 filings
Novo Nordisk INC.64 filings
Lincare61 filings
Amgen INC59 filings
PHRMA58 filings
Sarepta Therapeutics57 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.